BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 17219618)

  • 1. Five-year data out on Viread.
    AIDS Patient Care STDS; 2006 Dec; 20(12):887-8. PubMed ID: 17219618
    [No Abstract]   [Full Text] [Related]  

  • 2. Improvement of dyslipidemia during different HAART regimens: tenofovir- versus stavudine-containing antiretroviral combinations.
    Manfredi R
    Clin Infect Dis; 2006 May; 42(9):1345-7; author reply 1347-8. PubMed ID: 16586399
    [No Abstract]   [Full Text] [Related]  

  • 3. FDA grants tentative approval to first generic version of antiretroviral Viread.
    AIDS Patient Care STDS; 2008 Jan; 22(1):86. PubMed ID: 18453039
    [No Abstract]   [Full Text] [Related]  

  • 4. The impact of reducing stavudine dose versus switching to tenofovir on plasma lipids, body composition and mitochondrial function in HIV-infected patients.
    Milinkovic A; Martinez E; López S; de Lazzari E; Miró O; Vidal S; Blanco JL; Garrabou G; Laguno M; Arnaiz JA; Leon A; Larrousse M; Lonca M; Mallolas J; Gatell JM
    Antivir Ther; 2007; 12(3):407-15. PubMed ID: 17591031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved lipid profiles and maintenance of virologic control in heavily pretreated HIV-infected patients who switched from stavudine to tenofovir treatment.
    Schewe CK; Maserati R; Wassmer G; Adam A; Weitner L
    Clin Infect Dis; 2006 Jan; 42(1):145-7. PubMed ID: 16323105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV clinics are halting enrolment of new patients as funding stalls, MSF warns.
    Roehr B
    BMJ; 2009 Jul; 339():b2966. PubMed ID: 19620230
    [No Abstract]   [Full Text] [Related]  

  • 7. Tenofovir helpful for patients with HBV.
    AIDS Patient Care STDS; 2005 May; 19(5):347. PubMed ID: 15948275
    [No Abstract]   [Full Text] [Related]  

  • 8. FDA approves Viread for HIV-1 infection.
    FDA Consum; 2002; 36(1):5. PubMed ID: 11881601
    [No Abstract]   [Full Text] [Related]  

  • 9. Viread gets FDA nod.
    Rodriquez E
    Posit Living; 2001 Dec-2002 Jan; 10(7):33. PubMed ID: 11808509
    [No Abstract]   [Full Text] [Related]  

  • 10. 96-week CASTLE data show similar efficacy results.
    AIDS Patient Care STDS; 2008 Nov; 22(11):918. PubMed ID: 19043840
    [No Abstract]   [Full Text] [Related]  

  • 11. Tenofovir: what have over 1 million years of patient experience taught us?
    Pozniak A
    Int J Clin Pract; 2008 Aug; 62(8):1285-93. PubMed ID: 18705824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tenofovir works as pre-exposure prophylaxis against HIV, two studies confirm.
    Roehr B
    BMJ; 2011 Jul; 343():d4540. PubMed ID: 21765115
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of drug interactions and monitoring in the prevention of tenofovir-associated kidney disease.
    Winston JA; Shepp DH
    Clin Infect Dis; 2006 Jun; 42(11):1657-8; author reply 1658. PubMed ID: 16652330
    [No Abstract]   [Full Text] [Related]  

  • 14. HIV/AIDS. At last, vaginal gel scores victory against HIV.
    Cohen J
    Science; 2010 Jul; 329(5990):374-5. PubMed ID: 20643914
    [No Abstract]   [Full Text] [Related]  

  • 15. Comment on: suboptimal CD4 gains in HIV-infected patients receiving didanosine plus tenofovir.
    Anderson PL; Kakuda TN
    J Antimicrob Chemother; 2006 Jul; 58(1):220-1. PubMed ID: 16717052
    [No Abstract]   [Full Text] [Related]  

  • 16. FDA notifications. Updated Atripla label approved.
    AIDS Alert; 2010 Mar; 25(3):36. PubMed ID: 20629262
    [No Abstract]   [Full Text] [Related]  

  • 17. Early end for FEM-PrEP HIV prevention trial.
    AIDS Patient Care STDS; 2011 Jun; 25(6):383. PubMed ID: 21612547
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of the change from Stavudine to tenofovir in human immunodeficiency virus-infected children treated with highly active antiretroviral therapy: studies on mitochondrial toxicity and thymic function.
    Rosso R; Nasi M; Di Biagio A; Repetto E; Dentone C; Pinti M; Nemes E; Ferraresi R; Mussini C; Esposito R; Viscoli C; Cossarizza A
    Pediatr Infect Dis J; 2008 Jan; 27(1):17-21. PubMed ID: 18162932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. European CHMP issues positive opinion for Atripla.
    AIDS Patient Care STDS; 2007 Nov; 21(11):890. PubMed ID: 18338431
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of tenofovir in the prevention of HIV infections.
    De Clercq E
    AIDS; 2006 Oct; 20(15):1990-1. PubMed ID: 16988528
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.